Source:http://linkedlifedata.com/resource/pubmed/id/10511474
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-11-22
|
pubmed:abstractText |
1. The present work was aimed to study the effect of PKC activation and protein-serine/threonine phosphatase (PP1/PP2 A) inhibition on P-glycoprotein (P-gp) mediated transport of L-DOPA in LLC-GA5 Col300 cells, a renal cell line expressing the human P-glycoprotein in the apical membrane. 2. L-DOPA accumulation was a time-and concentration-dependent process with the following kinetic characteristics: kin, 57.3 +/- 1.2 pmol mg protein(-1) min(-1); k(out), 3.3 +/- 0.1 pmol mg(-1) protein min(-1); Amax, 10.6 +/- 0.8; Kn, 198 +/- 64 microM; Vmax, 5.2 +/- 0.7 nmol mg protein(-1). 3. Verapamil (25 microM), a P-glycoprotein inhibitor, markedly increased (approximately 40% increase) the accumulation of a non-saturating concentration of L-DOPA (2.5 microM) at both initial rate of uptake (IRU, 6 min incubation) and at steady-state (SS, 30 min incubation). 4. PKC activation with phorbol 12,13-dibutyrate (PDBu, 1, 3 and 10 nM) produced a concentration-dependent decrease in L-DOPA accumulation at SS, but not at IRU. The inactive phorbol ester, 4alpha-phorbol 12,13-didecanoate (100 nM), produced no change in L-DOPA accumulation. The effect of PDBu was completely reverted by staurosporine (100 nM). The phosphatase inhibitor okadaic acid (100 nM) reduced by 20% the accumulation of L-DOPA at IRU, but not at SS. 5. It is suggested that P-glycoprotein plays a role in regulation of intracellular availability of L-DOPA in renal epithelial cells, and phosphorylation/dephosphorylation of P-glycoprotein may be involved in the regulation of the transporter.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Levodopa,
http://linkedlifedata.com/resource/pubmed/chemical/Okadaic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Phorbols,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoric Monoester Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/Staurosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil,
http://linkedlifedata.com/resource/pubmed/chemical/phorbol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0144-1795
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
173-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10511474-Cells, Cultured,
pubmed-meshheading:10511474-Dose-Response Relationship, Drug,
pubmed-meshheading:10511474-Drug Interactions,
pubmed-meshheading:10511474-Epithelium,
pubmed-meshheading:10511474-Humans,
pubmed-meshheading:10511474-Kidney,
pubmed-meshheading:10511474-Levodopa,
pubmed-meshheading:10511474-Okadaic Acid,
pubmed-meshheading:10511474-P-Glycoprotein,
pubmed-meshheading:10511474-Phorbols,
pubmed-meshheading:10511474-Phosphoric Monoester Hydrolases,
pubmed-meshheading:10511474-Phosphorylation,
pubmed-meshheading:10511474-Protein Kinase C,
pubmed-meshheading:10511474-Staurosporine,
pubmed-meshheading:10511474-Time Factors,
pubmed-meshheading:10511474-Verapamil
|
pubmed:year |
1999
|
pubmed:articleTitle |
P-glycoprotein phosphorylation/dephosphorylation and cellular accumulation of L-DOPA in LLC-GA5 Col300 cells.
|
pubmed:affiliation |
Institute of Pharmacology & Therapeutics, Faculty of Medicine, Porto, Portugal.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|